Treatment of Inflammatory Bowel Disease with Biologics
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783319602752, 9783319602769

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Antitumor Necrosis Factor Agents in Crohn’s Disease

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_3 ◽

2017 ◽

pp. 33-48

Author(s):

Byron P. Vaughn

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Necrosis Factor

Download Full-text

Cessation of Biologics: Can It Be Done?

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_10 ◽

2017 ◽

pp. 141-162

Author(s):

Hang Hock Shim ◽

Cynthia H. Seow

Download Full-text

Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_9 ◽

2017 ◽

pp. 129-140

Author(s):

Afrin Kamal ◽

Bret Lashner

Keyword(s):

Ulcerative Colitis ◽

Crohn’S Disease ◽

Crohn's Disease ◽

Perioperative Risks

Download Full-text

Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_15 ◽

2017 ◽

pp. 261-282

Author(s):

Christina Y. Ha ◽

Asher Kornbluth

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

State Of The Art ◽

Inflammatory Bowel ◽

State Of The Science ◽

Art And State

Download Full-text

Use of Biologics in the Postoperative Management of Crohn’s Disease

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_5 ◽

2017 ◽

pp. 59-79

Author(s):

Benjamin H. Click ◽

Miguel Regueiro

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Postoperative Management

Download Full-text

Antitumor Necrosis Factor Agents in Ulcerative Colitis

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_2 ◽

2017 ◽

pp. 13-32

Author(s):

Kindra Clark-Snustad ◽

Ives Hot ◽

Scott Lee

Keyword(s):

Ulcerative Colitis ◽

Necrosis Factor

Download Full-text

Mechanism of Action and Pharmacokinetics of Biologics

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_1 ◽

2017 ◽

pp. 1-11

Author(s):

Alan C. Moss

Keyword(s):

Mechanism Of Action

Download Full-text

Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_4 ◽

2017 ◽

pp. 49-57

Author(s):

David I. Fudman ◽

Sarah N. Flier

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Extraintestinal Manifestations ◽

Inflammatory Bowel

Download Full-text

Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_13 ◽

2017 ◽

pp. 213-229 ◽

Cited By ~ 1

Author(s):

Julia T. Hughes ◽

Millie D. Long

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Therapeutic Drug Monitoring of Biologic Agents

Treatment of Inflammatory Bowel Disease with Biologics ◽

10.1007/978-3-319-60276-9_8 ◽

2017 ◽

pp. 113-128

Author(s):

Frank I. Scott ◽

Mark T. Osterman

Keyword(s):

Therapeutic Drug Monitoring ◽

Drug Monitoring ◽

Biologic Agents ◽

Therapeutic Drug

Download Full-text

Treatment of Inflammatory Bowel Disease with BiologicsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Antitumor Necrosis Factor Agents in Crohn’s Disease

Cessation of Biologics: Can It Be Done?

Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks

Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances

Use of Biologics in the Postoperative Management of Crohn’s Disease

Antitumor Necrosis Factor Agents in Ulcerative Colitis

Mechanism of Action and Pharmacokinetics of Biologics

Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease

Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy

Therapeutic Drug Monitoring of Biologic Agents

Treatment of Inflammatory Bowel Disease with Biologics
Latest Publications